Go Pro

Alpha Tau Medical (DRTS) Competitors

Alpha Tau Medical logo
$12.41 +0.23 (+1.91%)
As of 10:17 AM Eastern
This is a fair market value price provided by Massive. Learn more.

DRTS vs. IRTC, WRBY, ESTA, AXGN, and TMDX

Should you buy Alpha Tau Medical stock or one of its competitors? MarketBeat compares Alpha Tau Medical with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Alpha Tau Medical include iRhythm Technologies (IRTC), Warby Parker (WRBY), Establishment Labs (ESTA), AxoGen (AXGN), and TransMedics Group (TMDX). These companies are all part of the "medical equipment" industry.

How does Alpha Tau Medical compare to iRhythm Technologies?

Alpha Tau Medical (NASDAQ:DRTS) and iRhythm Technologies (NASDAQ:IRTC) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their valuation, dividends, risk, profitability, analyst recommendations, media sentiment, earnings and institutional ownership.

Alpha Tau Medical has higher earnings, but lower revenue than iRhythm Technologies. iRhythm Technologies is trading at a lower price-to-earnings ratio than Alpha Tau Medical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Alpha Tau MedicalN/AN/A-$42.63M-$0.67N/A
iRhythm Technologies$747.14M4.98-$44.55M-$0.86N/A

2.7% of Alpha Tau Medical shares are owned by institutional investors. 39.5% of Alpha Tau Medical shares are owned by insiders. Comparatively, 1.0% of iRhythm Technologies shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Alpha Tau Medical has a net margin of 0.00% compared to iRhythm Technologies' net margin of -3.53%. iRhythm Technologies' return on equity of -10.26% beat Alpha Tau Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Alpha Tau MedicalN/A -73.23% -52.90%
iRhythm Technologies -3.53%-10.26%-1.39%

Alpha Tau Medical presently has a consensus target price of $12.60, suggesting a potential upside of 1.51%. iRhythm Technologies has a consensus target price of $187.38, suggesting a potential upside of 65.36%. Given iRhythm Technologies' stronger consensus rating and higher possible upside, analysts clearly believe iRhythm Technologies is more favorable than Alpha Tau Medical.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Alpha Tau Medical
2 Sell rating(s)
1 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.29
iRhythm Technologies
1 Sell rating(s)
1 Hold rating(s)
12 Buy rating(s)
2 Strong Buy rating(s)
2.94

In the previous week, Alpha Tau Medical had 2 more articles in the media than iRhythm Technologies. MarketBeat recorded 5 mentions for Alpha Tau Medical and 3 mentions for iRhythm Technologies. iRhythm Technologies' average media sentiment score of 0.62 beat Alpha Tau Medical's score of 0.58 indicating that iRhythm Technologies is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Alpha Tau Medical
1 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
iRhythm Technologies
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Alpha Tau Medical has a beta of 1.17, indicating that its share price is 17% more volatile than the broader market. Comparatively, iRhythm Technologies has a beta of 1.27, indicating that its share price is 27% more volatile than the broader market.

Summary

iRhythm Technologies beats Alpha Tau Medical on 9 of the 16 factors compared between the two stocks.

How does Alpha Tau Medical compare to Warby Parker?

Alpha Tau Medical (NASDAQ:DRTS) and Warby Parker (NYSE:WRBY) are both medical equipment companies, but which is the better business? We will compare the two companies based on the strength of their analyst recommendations, risk, institutional ownership, valuation, dividends, earnings, profitability and media sentiment.

Alpha Tau Medical presently has a consensus target price of $12.60, indicating a potential upside of 1.51%. Warby Parker has a consensus target price of $29.82, indicating a potential upside of 10.00%. Given Warby Parker's stronger consensus rating and higher possible upside, analysts clearly believe Warby Parker is more favorable than Alpha Tau Medical.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Alpha Tau Medical
2 Sell rating(s)
1 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.29
Warby Parker
0 Sell rating(s)
5 Hold rating(s)
10 Buy rating(s)
0 Strong Buy rating(s)
2.67

Warby Parker has a net margin of 0.15% compared to Alpha Tau Medical's net margin of 0.00%. Warby Parker's return on equity of 2.30% beat Alpha Tau Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Alpha Tau MedicalN/A -73.23% -52.90%
Warby Parker 0.15%2.30%1.18%

In the previous week, Alpha Tau Medical had 1 more articles in the media than Warby Parker. MarketBeat recorded 5 mentions for Alpha Tau Medical and 4 mentions for Warby Parker. Alpha Tau Medical's average media sentiment score of 0.58 beat Warby Parker's score of 0.41 indicating that Alpha Tau Medical is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Alpha Tau Medical
1 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Warby Parker
2 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Warby Parker has higher revenue and earnings than Alpha Tau Medical. Alpha Tau Medical is trading at a lower price-to-earnings ratio than Warby Parker, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Alpha Tau MedicalN/AN/A-$42.63M-$0.67N/A
Warby Parker$871.91M3.33$1.64M$0.021,355.35

2.7% of Alpha Tau Medical shares are held by institutional investors. Comparatively, 93.2% of Warby Parker shares are held by institutional investors. 39.5% of Alpha Tau Medical shares are held by insiders. Comparatively, 16.8% of Warby Parker shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Alpha Tau Medical has a beta of 1.17, indicating that its share price is 17% more volatile than the broader market. Comparatively, Warby Parker has a beta of 1.91, indicating that its share price is 91% more volatile than the broader market.

Summary

Warby Parker beats Alpha Tau Medical on 12 of the 15 factors compared between the two stocks.

How does Alpha Tau Medical compare to Establishment Labs?

Establishment Labs (NASDAQ:ESTA) and Alpha Tau Medical (NASDAQ:DRTS) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their risk, media sentiment, profitability, institutional ownership, valuation, earnings, analyst recommendations and dividends.

Alpha Tau Medical has lower revenue, but higher earnings than Establishment Labs. Establishment Labs is trading at a lower price-to-earnings ratio than Alpha Tau Medical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Establishment Labs$211.08M11.83-$51.06M-$1.49N/A
Alpha Tau MedicalN/AN/A-$42.63M-$0.67N/A

In the previous week, Alpha Tau Medical had 3 more articles in the media than Establishment Labs. MarketBeat recorded 5 mentions for Alpha Tau Medical and 2 mentions for Establishment Labs. Establishment Labs' average media sentiment score of 0.94 beat Alpha Tau Medical's score of 0.58 indicating that Establishment Labs is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Establishment Labs
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Alpha Tau Medical
1 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Establishment Labs has a beta of 1.06, meaning that its stock price is 6% more volatile than the broader market. Comparatively, Alpha Tau Medical has a beta of 1.17, meaning that its stock price is 17% more volatile than the broader market.

Alpha Tau Medical has a net margin of 0.00% compared to Establishment Labs' net margin of -19.05%. Alpha Tau Medical's return on equity of -73.23% beat Establishment Labs' return on equity.

Company Net Margins Return on Equity Return on Assets
Establishment Labs-19.05% -218.77% -12.31%
Alpha Tau Medical N/A -73.23%-52.90%

72.9% of Establishment Labs shares are owned by institutional investors. Comparatively, 2.7% of Alpha Tau Medical shares are owned by institutional investors. 10.0% of Establishment Labs shares are owned by insiders. Comparatively, 39.5% of Alpha Tau Medical shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Establishment Labs presently has a consensus price target of $89.71, indicating a potential upside of 5.75%. Alpha Tau Medical has a consensus price target of $12.60, indicating a potential upside of 1.51%. Given Establishment Labs' stronger consensus rating and higher probable upside, analysts plainly believe Establishment Labs is more favorable than Alpha Tau Medical.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Establishment Labs
1 Sell rating(s)
1 Hold rating(s)
7 Buy rating(s)
0 Strong Buy rating(s)
2.67
Alpha Tau Medical
2 Sell rating(s)
1 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.29

Summary

Alpha Tau Medical beats Establishment Labs on 8 of the 15 factors compared between the two stocks.

How does Alpha Tau Medical compare to AxoGen?

Alpha Tau Medical (NASDAQ:DRTS) and AxoGen (NASDAQ:AXGN) are both medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, institutional ownership, dividends, risk, valuation, profitability, earnings and media sentiment.

2.7% of Alpha Tau Medical shares are owned by institutional investors. Comparatively, 80.3% of AxoGen shares are owned by institutional investors. 39.5% of Alpha Tau Medical shares are owned by company insiders. Comparatively, 2.4% of AxoGen shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

AxoGen has higher revenue and earnings than Alpha Tau Medical. AxoGen is trading at a lower price-to-earnings ratio than Alpha Tau Medical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Alpha Tau MedicalN/AN/A-$42.63M-$0.67N/A
AxoGen$225.21M9.22-$15.70M-$0.64N/A

In the previous week, Alpha Tau Medical had 1 more articles in the media than AxoGen. MarketBeat recorded 5 mentions for Alpha Tau Medical and 4 mentions for AxoGen. AxoGen's average media sentiment score of 1.08 beat Alpha Tau Medical's score of 0.58 indicating that AxoGen is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Alpha Tau Medical
1 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
AxoGen
1 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Alpha Tau Medical has a beta of 1.17, suggesting that its stock price is 17% more volatile than the broader market. Comparatively, AxoGen has a beta of 1.09, suggesting that its stock price is 9% more volatile than the broader market.

Alpha Tau Medical has a net margin of 0.00% compared to AxoGen's net margin of -13.21%. AxoGen's return on equity of -9.63% beat Alpha Tau Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Alpha Tau MedicalN/A -73.23% -52.90%
AxoGen -13.21%-9.63%-6.26%

Alpha Tau Medical currently has a consensus target price of $12.60, indicating a potential upside of 1.51%. AxoGen has a consensus target price of $46.50, indicating a potential upside of 19.10%. Given AxoGen's stronger consensus rating and higher probable upside, analysts clearly believe AxoGen is more favorable than Alpha Tau Medical.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Alpha Tau Medical
2 Sell rating(s)
1 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.29
AxoGen
1 Sell rating(s)
1 Hold rating(s)
9 Buy rating(s)
0 Strong Buy rating(s)
2.73

Summary

AxoGen beats Alpha Tau Medical on 10 of the 15 factors compared between the two stocks.

How does Alpha Tau Medical compare to TransMedics Group?

TransMedics Group (NASDAQ:TMDX) and Alpha Tau Medical (NASDAQ:DRTS) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their valuation, analyst recommendations, media sentiment, dividends, earnings, profitability, risk and institutional ownership.

TransMedics Group has a net margin of 27.04% compared to Alpha Tau Medical's net margin of 0.00%. TransMedics Group's return on equity of 22.38% beat Alpha Tau Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
TransMedics Group27.04% 22.38% 8.46%
Alpha Tau Medical N/A -73.23%-52.90%

TransMedics Group has higher revenue and earnings than Alpha Tau Medical. Alpha Tau Medical is trading at a lower price-to-earnings ratio than TransMedics Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
TransMedics Group$605.49M4.25$190.29M$4.4016.94
Alpha Tau MedicalN/AN/A-$42.63M-$0.67N/A

99.7% of TransMedics Group shares are held by institutional investors. Comparatively, 2.7% of Alpha Tau Medical shares are held by institutional investors. 6.9% of TransMedics Group shares are held by company insiders. Comparatively, 39.5% of Alpha Tau Medical shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

TransMedics Group has a beta of 1.89, suggesting that its stock price is 89% more volatile than the broader market. Comparatively, Alpha Tau Medical has a beta of 1.17, suggesting that its stock price is 17% more volatile than the broader market.

In the previous week, TransMedics Group had 1 more articles in the media than Alpha Tau Medical. MarketBeat recorded 6 mentions for TransMedics Group and 5 mentions for Alpha Tau Medical. TransMedics Group's average media sentiment score of 0.65 beat Alpha Tau Medical's score of 0.58 indicating that TransMedics Group is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
TransMedics Group
3 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Alpha Tau Medical
1 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

TransMedics Group presently has a consensus price target of $134.50, suggesting a potential upside of 80.48%. Alpha Tau Medical has a consensus price target of $12.60, suggesting a potential upside of 1.51%. Given TransMedics Group's stronger consensus rating and higher probable upside, equities analysts clearly believe TransMedics Group is more favorable than Alpha Tau Medical.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
TransMedics Group
1 Sell rating(s)
6 Hold rating(s)
6 Buy rating(s)
0 Strong Buy rating(s)
2.38
Alpha Tau Medical
2 Sell rating(s)
1 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.29

Summary

TransMedics Group beats Alpha Tau Medical on 14 of the 15 factors compared between the two stocks.

Get Alpha Tau Medical News Delivered to You Automatically

Sign up to receive the latest news and ratings for DRTS and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding DRTS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

DRTS vs. The Competition

MetricAlpha Tau MedicalMED INSTRUMENTS IndustryMedical SectorNASDAQ Exchange
Market Cap$1.13B$7.41B$6.76B$12.50B
Dividend YieldN/A1.32%2.68%8.00%
P/E Ratio-18.6349.9426.9324.41
Price / SalesN/A75.78586.18117.36
Price / CashN/A26.8529.2249.36
Price / Book14.117.2010.946.33
Net Income-$42.63M$162.30M$3.58B$330.66M
7 Day Performance-2.72%-1.61%-2.10%-0.66%
1 Month Performance26.02%-0.48%3.21%-0.14%
1 Year Performance284.30%3.46%26.34%20.16%

Alpha Tau Medical Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
DRTS
Alpha Tau Medical
1.8186 of 5 stars
$12.41
+1.9%
$12.60
+1.5%
+298.0%$1.13BN/AN/A80
IRTC
iRhythm Technologies
3.7978 of 5 stars
$118.95
+0.4%
$187.38
+57.5%
-12.7%$3.89B$747.14MN/A2,400
WRBY
Warby Parker
2.8789 of 5 stars
$30.33
+0.7%
$29.82
-1.7%
+23.7%$3.22B$871.91M1,517.164,036
ESTA
Establishment Labs
1.2964 of 5 stars
$85.81
-1.8%
$87.14
+1.6%
+95.8%$2.57B$211.08MN/A1,004
AXGN
AxoGen
3.2029 of 5 stars
$46.19
+3.3%
$46.50
+0.7%
+232.1%$2.38B$225.21MN/A450

Related Companies and Tools


This page (NASDAQ:DRTS) was last updated on 7/14/2026 by MarketBeat.com Staff.
From Our Partners